These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
606 related items for PubMed ID: 8592483
1. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure. Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD. Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483 [Abstract] [Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
3. Rapid correction of metabolic acidosis in chronic renal failure: effect on parathyroid hormone activity. Lu KC, Shieh SD, Li BL, Chu P, Jan SY, Lin YF. Nephron; 1994 Nov; 67(4):419-24. PubMed ID: 7969674 [Abstract] [Full Text] [Related]
4. Influence of rapid correction of metabolic acidosis on serum osteocalcin level in chronic renal failure. Lin YF, Shieh SD, Diang LK, Lin SH, Chyr SH, Li BL, Lu KC. ASAIO J; 1994 Nov; 40(3):M440-4. PubMed ID: 8555554 [Abstract] [Full Text] [Related]
5. Acute correction of metabolic acidosis increases serum procollagen type I carboxyterminal propeptide in patients with chronic renal failure. Chu P, Lu KC, Lin YF. J Formos Med Assoc; 2001 Nov; 100(11):748-52. PubMed ID: 11802533 [Abstract] [Full Text] [Related]
6. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Zisman AL, Hristova M, Ho LT, Sprague SM. Am J Nephrol; 2007 Nov; 27(1):36-43. PubMed ID: 17215573 [Abstract] [Full Text] [Related]
7. Chronic metabolic acidosis increases the serum concentration of 1,25-dihydroxyvitamin D in humans by stimulating its production rate. Critical role of acidosis-induced renal hypophosphatemia. Krapf R, Vetsch R, Vetsch W, Hulter HN. J Clin Invest; 1992 Dec; 90(6):2456-63. PubMed ID: 1469097 [Abstract] [Full Text] [Related]
8. [Review of the concept of vitamin D "sufficiency and insufficiency"]. Gómez Alonso C, Naves Díaz M, Rodríguez García M, Fernández Martín JL, Cannata Andía JB. Nefrologia; 2003 Dec; 23 Suppl 2():73-7. PubMed ID: 12778859 [Abstract] [Full Text] [Related]
9. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB. J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962 [Abstract] [Full Text] [Related]
10. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure. Martin-Malo A, Rodriguez M, Martinez ME, Torres A, Felsenfeld AJ. Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210 [Abstract] [Full Text] [Related]
11. Correction of chronic metabolic acidosis in haemodialysed patients by acetate-free biofiltration does not influence parathyroid function. de Précigout V, Combe C, Blanchetier V, Larroumet N, Pommereau A, Potaux L, Aparicio M. Nephrol Dial Transplant; 1995 Aug; 10(6):821-4. PubMed ID: 7566610 [Abstract] [Full Text] [Related]
12. [Treatment of secondary hyperparathyroidisms of predialysis chronic renal failure with low doses of 1.25(OH)2D3]. Kato N, Kasai K, Kawaguchi Y, Yamamoto H, Shigematu T, Sakai O. Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):543-8. PubMed ID: 7474506 [Abstract] [Full Text] [Related]
13. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. Blair D, Byham-Gray L, Lewis E, McCaffrey S. J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303 [Abstract] [Full Text] [Related]
14. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P. Miner Electrolyte Metab; 1985 Jul; 11(6):358-68. PubMed ID: 3877862 [Abstract] [Full Text] [Related]
15. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients. Lee SH, Huang TS, Hsieh SJ. Miner Electrolyte Metab; 1996 Jul; 22(4):219-23. PubMed ID: 8807625 [Abstract] [Full Text] [Related]
16. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM, Youssef AM, Zayoon MY. Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [Abstract] [Full Text] [Related]
17. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. Movilli E, Viola BF, Camerini C, Mazzola G, Cancarini GC. J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045 [Abstract] [Full Text] [Related]
18. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296 [Abstract] [Full Text] [Related]
19. Vitamin D3 metabolites in chronic renal failure and after renal transplantation. Lucas PA, Woodhead JS, Brown RC. Nephrol Dial Transplant; 1988 Jul; 3(1):70-6. PubMed ID: 3132643 [Abstract] [Full Text] [Related]
20. Sevelamer worsens metabolic acidosis in hemodialysis patients. De Santo NG, Frangiosa A, Anastasio P, Marino A, Correale G, Perna A, Di Stazio E, Stellato D, Santoro D, Di Meglio E, Iacono G, Ciacci C, Savica V, Cirillo M. J Nephrol; 2006 Jul; 19 Suppl 9():S108-14. PubMed ID: 16736432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]